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Abstract
Background: To establish the impact of tobacco smoking on mortality is essential to define and
monitor public health interventions in developing countries.
Methods:  The Smoking-Attributable Mortality, Morbidity and Economic Costs (SAMMEC)
software was used to estimate the smoking attributable mortality (SAM) in 15 Brazilian State
Capitals and the Federal District for the year 2003. Smoking prevalence and mortality data of
people aged 35 years or older were obtained for each city from the Brazilian Household Survey on
Non Communicable Diseases Risk Factors (2002–2003) and from the Brazilian Mortality System
(2003), respectively.
Results: In 2003, of the 177,543 deaths of persons aged 35 years and older 24,222 (13.64%) were
attributable to cigarette smoking. This total represents 18.08% of all male deaths (n = 16,896) and
8.71% (n = 7,326) of all female deaths in these cities. The four leading causes of smoking-attributable
death were chronic airways obstruction (4,419 deaths), ischemic heart disease (4,417 deaths), lung
cancer (3,682 deaths), and cerebrovascular disease (3,202 deaths). Cigarette smoking accounted
for 419,935 years of potential life lost (YPLL) (279,990 YPLL for men and 139,945 YPLL for women)
in the same period.
Conclusion: Tobacco use caused one out of five male deaths and one out of ten female deaths in
the sixteen cities in 2003. Four leading causes of smoking attributable deaths (ischemic heart
disease, chronic airways obstruction, lung cancer and cerebrovascular disease) accounted for 64.9%
of SAM. Effective and comprehensive actions must be taken in order to slow this epidemic in Brazil.
Background
Scientific evidence of harm caused by smoking has been
accumulating for over 200 years, at first in relation to can-
cers of the lip and mouth, and then in relation to vascular
diseases and lung cancer [1]. Epidemiologic studies have
estimated disease risks associated with various smoking
patterns. At present, nearly 40 diseases or causes of death
are known to be positively associated with cigarette smok-
ing [1]. As a result of these findings, in the next 50 years,
tobacco use is projected to cause nearly 450 million
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deaths worldwide [2]. It is expected that by 2020–2030,
approximately 7 million deaths attributable to tobacco
will occur per year in developing countries [3].
Counting and establishing the causes of deaths is a matter
of concern for the public health community. Two of the
Millennium Development Goals express targets in terms
of mortality, which is also one of the three components of
the Human Development Index [4]. Information on
deaths is crucial to the planning, implementation and
evaluation of public health programs at local, national
and international levels.
The number of deaths caused by tobacco use in a popula-
tion (the smoking-attributable mortality, SAM) can be
estimated by different methodologies [5-7]. The popula-
tion attributable risk (PAR) methodology is the most
commonly used [5]. PAR incorporates the prevalence of
smoking and the relative risk (RR) associated with various
amounts of smoking [5-7]. Adult Smoking-Attributable
Mortality, Morbidity and Economic Costs (SAMMEC), an
online application developed by the Centers for Disease
Control and Prevention (CDC), use attributable risk for-
mulas to estimate the number of deaths from cancer, car-
diovascular and respiratory diseases associated with
cigarette smoking [8]. SAMMEC has been applied in
United States and other countries such as Australia [9],
Canada [10] and Spain [11].
In developed countries, data on major health risk factors
are regularly obtained from population surveys and mor-
bidity specific registers such as those for cancer. Many
developing countries have reasonably reliable data on
mortality by cause, but lack population data on the prev-
alence of risk factors, such as smoking, which are essential
to establish public health policy priorities. In Brazil, direct
estimates of mortality cannot be made because there is a
lack of longitudinal studies on the differential mortality of
smokers, former smokers and non-smokers, necessary to
provide RR estimates for smoking-related diseases and
mortality. Attempts to produce indirect estimates are
needed, because an important share of the global tobacco
burden falls on developing countries, where 84% of the
1.3 billion current smokers reside [12]. In 2002 smoking-
related mortality in Brazil was estimated at around
200,000 a year [13]. In 2003, the Ministry of Health con-
ducted a large population-based survey in 16 Brazilian
capitals [14] to assess the prevalence of smoking and sev-
eral other risk factors. The results of the survey allowed,
along with other information, to estimate for the first time
the number of smoking attributable deaths and the years
of potential life lost (YPLL) in these capitals. In order to
assist the reader with interpreting the results we have pro-
vided a map of Brazil and the capitals included in the
study as an additional file.
Methods
After considering all the methods that could be used to
estimate SAM in Brazil [6], we decided to use the PAR
method. A direct estimate of the SAM in Brazil is not pos-
sible since the smoking status of decedents is not rou-
tinely collected on the death certificate and relative risk
estimates for cause specific mortality related to tobacco
use in Brazil are not available. The PAR method was
selected because it is frequently used throughout the
world and because of the availability of a free computa-
tional tool on the internet, with relative risks adjusted for
age and sex (SAMMEC) [6]. The smoking impact ratio
(SIR) method proposed by Peto [15,16] is complex and
there is no easy access to technical assistance unlike the
SAMMEC method. In addition, the SIR calculation
requires lung cancer mortality rates in never smokers,
which are not available in Brazil.
SAMMEC was used to calculate age-adjusted SAM rates for
persons aged 35 years and older, using age, sex and cause
specific mortality rates, current smoking prevalence by age
group and sex in the same period [8], and the American
Cancer Society's Cancer Prevention Study II (CPS-II) rela-
tive risks [17]. The CPS-II is an ongoing prospective study
of 1,185,106 residents in United States, aged 30 years or
over, for those who, in 1982, had never smoked regularly,
and for those who were then current cigarette smokers
[15]. The cause-specific RR for a smoking-related disease
represents the ratio of mortality among current or former
smokers to mortality among those who never smoked
[17]. We used these RR estimates because they are robust;
the age of initiation of smoking in Brazil and US are sim-
ilar [18] and both Brazil and U.S experienced a significant
decrease in the number of cigarettes smoked per day in
relation to what occurred at the beginning of the 90s
[19,20].
In the present study, data from the 2000 Demographic
Census, according to sex and five-year age group, provided
the denominators for mortality rates of persons aged 35
years and over [21]. The 2003 mortality data for 22 adult
smoking-related diseases were drawn from the Brazilian
Mortality System, available from the Brazilian Health
Database (DATASUS) [22]. Mortality rates for each city
were then age-standardized using the age distribution of
the total Brazilian population in the same year [21].
Deaths were categorized by cause, city of residence, sex
and age group. Causes were coded using the International
Classification of Diseases (ICD), 10th Revision. Data on
deaths from burns or second hand smoke were not avail-
able and therefore were not included in the present study.
Smoking prevalence rates for adults aged 35 years or older
were obtained from the database of the Brazilian House-
hold Survey on Non-Communicable Diseases Risk FactorsBMC Public Health 2009, 9:206 http://www.biomedcentral.com/1471-2458/9/206
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and Self-Reported Morbidity [14]. The target population
of this survey consisted of individuals aged 15 years or
older who lived in 16 Brazilian cities. The survey included
all State capitals of the South and Southeast regions; two
out of four State capitals of the Central-West region, five
out of nine State capitals of the Northeast region and two
out of seven State capitals of the North region. Altogether
the population of these 16 State capitals accounted for
about 20% of the Brazilian total population in 2000 [21].
In this survey, smokers were defined as those who
reported, at the time of the interview, smoking cigarettes
every day and had smoked at least a hundred cigarettes in
their lifetime. In the absence of information on the total
number of cigarettes or similar products smoked by non-
daily smokers (approximately 10% of total smokers), a
consumption equivalent to one cigarette per day was
attributed to these non-daily smokers [19]. A total of
23,457 participants were interviewed (10,175 males and
13,282 females) [14]. Current and former smoker rates,
by city, sex and two different age groups (35–64 years and
≥ 65 years) were drawn from the survey database using
STATA 9.2 software [23].
SAMMEC calculates YPLL multiplying the SAM estimates
for each age group, stratified by sex and underlying cause
of death by the life expectancy of people at the midpoint
of each age range. The resulting numbers for each age
group are added to obtain YPLL by sex [8] and group of
cause. The total YPLL is the sum of the male and female
YPLL for cancer, cardiovascular and respiratory diseases.
Data to estimate YPLL was obtained from the Brazilian
Institute of Geography and Statistics (IBGE) [24]. SAM-
MEC uses life expectancies estimates for five-year age cat-
egories from 35–39 to 85 + years. As IBGE does not
provide life expectancies for people over 80 years of age
[21], we applied the same life expectancy of age group 75–
79 to those aged 80 + years.
Our study uses secondary data published and available for
use by the Brazilian Ministry of Health. Resolution N°
196/96 on Research Involving Human Subjects states that
ethical clearance to perform an analysis based on second-
ary data in the public domain is not necessary[25].
Results
The prevalence of current and former smoking by city, sex
and two age groups (35–64 years and ≥ 65 years) are
shown in Table 1. The prevalence of smokers and ex-
smokers are much higher among men, with the latter cat-
egory being generally higher than the former one, espe-
cially among older adults.
In 2003, a total of 177,543 deaths of individuals aged 35
years and older (93,431 males; 84,112 females) were
reported in the 16 State capitals. From this total, 83,593
deaths were linked to smoking; 27 deaths were assigned to
the ICD-10 code F17.2 (tobacco dependence syndrome)
but no underlying (or primary) tobacco-related cause was
reported. For this reason, these deaths were excluded, thus
83,566 deaths remained for the estimation of SAM. A total
of 24,222 deaths (13.64% of all deaths and 28.99% of all
smoking-related diseases deaths) were caused by smok-
ing. The male-to-female SAM ratio was equal to 2.31
(Table 2).
Table 2 presents the number of smoking-attributable
deaths by sex grouped into three broad categories: cancer,
cardiovascular and respiratory diseases. Cardiovascular
diseases were the most frequent cause, responsible for
10,274 of all smoking attributable deaths, followed by
cancer (7,332 deaths) and respiratory diseases (6,616
deaths). The four leading specific causes of adult smoking-
attributable deaths were chronic airways obstruction
(4,419 deaths), ischemic heart disease (4,417 deaths),
lung cancer (3,682 deaths) and cerebrovascular disease
(3,202 deaths). Combined, these four conditions were
responsible for 64.9% of all SAM (15,720/24,222). Males
and females differed slightly in the ranking of the four
leading causes of smoking attributable deaths. Among
males they were: ischemic heart disease (IHD), chronic
airways obstruction, lung cancer and cerebrovascular dis-
ease. Among females they were chronic airways obstruc-
tion, cerebrovascular disease, ischemic heart disease and
lung cancer.
Of the total smoking-attributable deaths, 81.1% occurred
in six cities: São Paulo (9,201); Rio de Janeiro (5,076);
Porto Alegre (1,573); Belo Horizonte (1,394); Curitiba
(1,360) and Recife (1,029). Table 3 presents age-adjusted
SAM rates per 100,000 Brazilians for these cities. Curitiba
had the highest age-adjusted SAM rates, followed by Porto
Alegre, São Paulo, Recife, Rio de Janeiro, and Belo Hori-
zonte. Additional files are available for each one of the 16
Brazilian capitals. Each additional file contains 3 Micro-
soft Excel spreadsheets: spreadsheet 1 shows Mortality
Smoking-Attributable Fractions by Sex and Age; spread-
sheet 2 displays Smoking-Attributable Mortality, whereas
spreadsheet 3 shows Age-Adjusted SAM Rate per 100,000
[additional files 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16 and 17].
In the same period, smoking accounted for 279,990 YPLL
among men and 139,945 YPLL among women. Cardio-
vascular diseases were the leading cause of smoking-
attributable YPLL, causing 198,167 YPLL (Table 4).
Discussion
To our knowledge, this is the first study to estimate SAM
in Brazil using population based data on smoking preva-BMC Public Health 2009, 9:206 http://www.biomedcentral.com/1471-2458/9/206
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Table 1: Percentages of current and former smokers by city, gender and two different age groups. Brazil, 2003.
City Age Category Male Female
Current Smoker Former Smoker Current Smoker Former Smoker
Aracaju 35–64 20.95 26.35 15.64 21.33
65+ 21.05 31.58 6.90 0.00
Belém 35–64 28.77 33.33 17.74 18.39
65+ 23.81 42.86 4.55 30.30
Belo Horizonte 35–64 33.49 35.42 20.95 24.41
65+ 13.79 60.34 2.40 20.00
Brasília 35–64 26.42 34.38 19.78 22.86
65+ 12.12 30.30 8.62 18.97
Campo Grande 35–64 21.43 40.48 14.67 21.20
65+ 5.00 45.00 10.00 5.00
Curitiba 35–64 26.00 30.87 21.59 20.13
65+ 13.85 50.77 12.20 17.07
Florianópolis 35–64 28.96 34.43 24.55 16.96
65+ 10.00 56.67 5.77 11.54
Fortaleza 35–64 27.50 35.75 19.66 24.72
65+ 14.75 50.82 4.85 22.33
João Pessoa 35–64 34.74 23.16 15.33 16.33
65+ 12.50 42.50 8.20 13.11
Manaus 35–64 30.08 24.06 16.96 20.76
65+ 22.22 46.67 6.25 29.17
Natal 35–64 26.36 27.13 18.56 18.56
65+ 14.29 50.00 2.38 23.81
Porto Alegre 35–64 32.14 33.93 27.27 25.13
65+ 13.43 64.18 7.14 15.31
Recife 35–64 27.66 32.45 20.00 20.00
65+ 23.68 36.84 5.88 19.12BMC Public Health 2009, 9:206 http://www.biomedcentral.com/1471-2458/9/206
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lence. Cigarette smoking was responsible for 13.6% of all
adult deaths in the studied population.
Smoking prevalence in Latin America varies widely, not
only between countries but also within countries [26].
The percentage of smokers in Brazil is closer to that in the
USA (20.8% in 2004) and Canada (20% in 2005) and
much lower than in some Latin American countries such
as Cuba (37.2% in 1995) and Argentina (40.4% in 2000)
[19]. Although smoking prevalence in Mexico is similar to
that of many high-income countries, especially for men
(36% for men and 13% for women), nearly half of smok-
ers do not smoke daily, and most of the remaining smoke
fewer than five cigarettes per day [27]. The picture is quite
different from the one seen in Brazil, where nearly 30% of
smokers smoke 20 or more cigarettes per day and approx-
imately 10% of total smokers are non-daily smokers [19].
Differences in SAM largely reflect the stage of the smoking
epidemic in each country [26], but the above data show
that the number of cigarettes smoked per day also plays a
role. A larger proportion of deaths in people aged ≥ 35
years has been found in the nearby country of Argentina
(16% vs. 13.6%) with a male-to-female SAM ratio equal
to 2.50 (21% of death among males and 10% among
females) [28], slightly higher than the ratio found in Bra-
zil (2.31). In South Africa, also a developing country,
smoking accounted for 8.0 to 9.0% of deaths, with three
times as many deaths occurring in males compared with
females [29].
The SAM in Mexico in 2004 is much lower than the one
observed in this work (5.2% of total deaths; 6.0% in men
and 4.3% in women) [27]. The largest proportional effect
of tobacco smoking on mortality and burden of disease
was in the wealthiest regions of Mexico, particularly the
Northern region, where it was responsible for 9% of
deaths [27]. Because prevalence of smoking in Mexico is
higher than in Brazil, such difference in SAM is likely to
reflect, at least in part, to the lesser amount of cigarettes
smoked daily in Mexico [27].
As seen in Brazil, males and females differed in the rank-
ing of the leading causes of smoking attributable deaths,
but the causes were different from ours. While in Argen-
tina the two top killers among men were lung cancer
(22%) and cerebrovascular disease (18%) [28], in Brazil
they were ischemic heart disease (18.7%) and respiratory
diseases (16.8%), followed by lung cancer (15.6%).
Among Argentinean females, the leading cause is other
heart disease (21%) [28], while in Brazil chronic airway
obstruction alone is responsible for 21%.
Combining the four leading causes of smoking attributa-
ble deaths in the 16 cities in 2003 – ischemic heart dis-
ease, chronic airways obstruction, lung cancer, and
cerebrovascular disease – account for 64.9% of the SAM.
These diseases are among the most important causes of
death in the country. In 2003, for instance, cardiovascular
diseases, cancer and respiratory diseases together were
responsible for 58% of all adult deaths in Brazil [30].
Thus, these results suggest that a large proportion of these
deaths would be prevented by further reductions in smok-
ing prevalence.
Our findings suggest that cigarette smoking accounted for
419,935 YPLL for adults in the 16 cities in 2003. Cardio-
vascular diseases were the leading cause of smoking-
attributable YPLL. YPLL emphasizes the causes of death
occurring in younger persons, thus assisting health policy
makers in identifying health priorities.
Important issues, such as the quality and coverage of the
cause-of-death statistics, need to be considered when
using mortality data to evaluate the health situation of a
country [31]. Mathers et al analyzed the death registration
system of 115 countries to determine the percentage of
causes of deaths coded as unknown and ill-defined [32].
Based on these results, data quality for Brazil was catego-
rized as medium. However, the Brazilian Mortality System
is far better in the State capitals and in the South and
Southeast regions of the country and has improved con-
siderably in recent years. Thus, the estimates of SAM in the
Rio de Janeiro 35–64 25.68 35.52 22.80 23.30
65+ 16.96 50.89 5.13 11.79
São Paulo 35–64 30.42 33.75 19.87 25.64
65+ 25.00 34.38 9.09 18.18
Vitória 35–64 24.03 32.47 17.20 17.20
65+ 7.69 69.23 8.11 18.92
Table 1: Percentages of current and former smokers by city, gender and two different age groups. Brazil, 2003. (Continued)BMC Public Health 2009, 9:206 http://www.biomedcentral.com/1471-2458/9/206
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Table 2: Numbers and percentages of smoking-attributable deaths1 according to disease group and sex among people aged ≥ 35 years 
in 16 Brazilians cities, 2003.
Disease Category ICD-10 Male (%) Female (%) Total
Malignant Neoplasms
Lip, Oral Cavity, Pharynx C00-14 827 (4.89) 97 (1.32) 924 (3.81)
Oesophagus C15 664 (3.92) 134 (1.83) 798 (3.29)
Stomach C16 498 (2.95) 86 (1.17) 584 (2.41)
Pancreas C25 157 (0.93) 137 (1.87) 294 (1.21)
Larynx C32 533 (3.15) 52 (0.71) 585 (2.42)
Trachea, Lung, Bronchus C33-34 2632 (15.58) 1050 (14.33) 3682 (15.20)
Cervix Uteri C53 0 (0) 94 (1.28) 94 (0.39)
Kidney and Renal Pelvis C64-66, C68 119 (0.70) 0 (0) 119 (0.49)
Urinary Bladder C67 206 (1.22) 36 (0.49) 242 (1.00)
Acute Myeloid Leukaemia C92.0 36 (0.21) 10 (0.14) 46 (0.19)
Sub-total 5636 (33.36) 1696 (23.15) 7332 (30.27)
Cardiovascular Diseases
Ischemic Heart Disease I20-25 3151 (18.65) 1266 (17.28) 4417 (18.24)
Other Heart Disease I00-09, I26-28, I30-51 1102 (6.52) 405 (5.53) 1507 (6.22)
Cerebrovascular Disease I60-69 1863 (11.03) 1339 (18.28) 3202 (13.22)
Atherosclerosis I70 44 (0.26) 9 (0.12) 53 (0.22)
Aortic Aneurysm I71 701 (4.15) 297 (4.05) 998 (4.12)
Other Arterial Disease I72-78 58 (0.34) 39 (0.53) 97 (0.40)
Sub-total 6919 (40.95) 3355 (45.80) 10274 (42.42)
Respiratory Diseases
Pneumonia, Influenza J10-18 899 (5.32) 452 (6.17) 1351 (5.58)
Bronchitis, Emphysema J40-43 603 (3.57) 243 (3.32) 846 (3.49)
Chronic Airway Obstruction J44 2839 (16.80) 1580 (21.57) 4419 (18.24)
Sub-total 4341 (25.69) 2275 (31.05) 6616 (27.31)
Total 16896 (100) 7326(100) 24222(100)
1 Does not include burn or second hand smoke deaths.BMC Public Health 2009, 9:206 http://www.biomedcentral.com/1471-2458/9/206
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cities located in these two regions are likely to express the
actual number of smoking attributable deaths. On the
other hand, in the seven cities of the North and Northeast,
the estimated number of smoking attributable deaths is
probably lower than the real one, due to the greater per-
centage of deaths classified as unknown or ill defined.
The list of smoking-attributable diseases in SAMMEC does
not include colorectal cancer among the malignancies.
Studies in various populations show an association
between tobacco use and colorectal cancer [33,34]. Recent
Nurse's Health Study evidence found that current smok-
ing was associated with an increased risk of colorectal can-
cer mortality [35]. The addition of colorectal cancer to the
list of tobacco-associated malignancies would further
increase the SAM and YPLL estimates presented in our
work. The SAM and YPLL described in this report also rep-
resent a conservative estimate because the calculations did
not include deaths from cancers at unspecified sites. Two
recent meta-analyses discuss the potential association
between smoking and mortality from tuberculosis (TB)
[36,37], but this contribution is still controversial, so TB
has not been included in the present study.
Another question that needs consideration when inter-
preting SAM is the different induction periods between
tobacco exposure and disease manifestation and death,
which can reach two to three decades for some types of
cancer. The use of the CDC method in calculating SAM
requires the assumption of a steady state of smoking prev-
alence and mortality risks [38]. In periods of fast decline
in smoking prevalence, the attributable-fraction method-
ology will tend to understate the number of deaths caused
by smoking [39], because the deaths occurred in one year
results from exposure occurring in the past, when preva-
lence was much higher. Between 1989 and 2003, the esti-
mated prevalence of smokers among the Brazilian adult
population declined approximately 35%, going from
34.8% in 1989 to 22.4% in 2003 or an average reduction
of 2.5% per year [19]. As a consequence of such decline,
the prevalences of smoking applied in the present study
are lower than the ones at the relevant induction periods
for most causes included by SAMMEC. Thus, the SAM esti-
mates are probably conservative and the impact of this
smoking decline in mortality will be felt only after twenty
or more years from now.
Translating attributable risk into a number of excess
deaths that would not have occurred had the exposure not
existed relies on the assumptions that CPS-II relative risks
used in the calculation of SAM are applicable to the Bra-
zilian population and that confounding by other risk fac-
tors does not introduce a significant bias. However, CPS-
II risks are based on large samples of volunteers and
friends of the American Cancer Society, a predominantly
affluent portion of the US population, including physi-
cians and health care workers and their spouses. For
instance, a study found that CPS-II samples differ in many
aspects from the US general population [40]. In respect to
Brazil, such differences are expected to be magnified, both
in relation to smoking patterns and to the distribution of
other relevant confounding factors (such as alcohol in
relation to some cancers) for the diseases included in
SAM. Furthermore, educational and socio-economic lev-
els are important variables associated with cigarette smok-
ing and mortality and are certainly not the same in CPS-II
and Brazilian populations. However, it is difficult to value
the effect of such differences in our estimates. Studies car-
ried out in the USA that estimated the effect of confound-
ing from these variables in the calculation of the mortality
attributable to smoking resulted in an overestimation of
only 1%–2.5% [41]. In Spain, the use of CPS-II risks
seems to have underestimated SAM [11]. In Brazil, we do
not have any study which has estimated such effect, but
we can further conjecture about the bias introduced by the
use of CPS-II RR. Peto et al observed that the level of lung
cancer mortality compared with never-smokers is an indi-
cator of the accumulated hazard of smoking and the
"maturity" of the smoking epidemic in a population [15].
Two important facts concerning the tobacco epidemic in
Brazil should be considered: 1) the country experienced a
large increase in consumption of cigarettes one decade
later than the United States and the United Kingdom [42]
and 2) the level of consumption per capita was always
much lower in Brazil than in the US, Canada and Euro-
pean Union countries such as France, Germany and Italy,
even at its pick in the 1980s [42]. It follows that RR in Bra-
zil is expected to be smaller than CPS II relative risks
because of the maturation factor; thus the use of CPS II
relative risks has overestimated mortality in this study.
Environmental factors interacting with smoking are differ-
ent in Brazil, compared to the U.S.: levels of outdoor and
indoor pollution, passive smoking, silica and asbestos use
could modify the effects of smoking in Brazilian popula-
tion in a non-multiplicative way [15]. Nonetheless, CPS-
II relative risks are based on very large samples and have
been applied to other populations; therefore were the best
estimates we could use.
The 16 cities studied had altogether 32,851,808 inhabit-
ants in 2000, 19.34% of Brazil's total population (169,
872, 856 inhabitants) [21]. Despite considering that over
80% of the Brazilian population is urban, and the vast
majority live in large population centres [21] we cannot
extrapolate with certainty that the results of the present
study apply to the whole country. Brazil is a continental
country in which smoking prevalence varies both between
and within Brazilian states. For instance, in 2003 the
smoking prevalence in Porto Alegre – capital of Rio
Grande do Sul state – was 25.2% (CI 95% 22.4–28.1)BMC Public Health 2009, 9:206 http://www.biomedcentral.com/1471-2458/9/206
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Table 3: Age-adjusted smoking attributable mortality (SAM)1,2 rates per 100,000 inhabitants, according to cause of death in selected 
cities, Brazil, 2003.
São Paulo Rio de Janeiro Porto Alegre Belo Horizonte Curitiba Recife
Disease Category
Malignant Neoplasms
Lip, Oral Cavity, Pharynx 8.2 7.9 6.9 5.8 10.3 6.9
Oesophagus 7.7 4.9 10.2 7.4 10.7 4.1
Stomach 5.7 3.6 4.4 4.6 4.2 3.5
Pancreas 3.0 2.2 2.7 2.2 3.1 3.2
Larynx 5.7 4.3 4.8 3.5 4.2 4.9
Trachea, Lung, Bronchus 30.1 29.5 48.6 23.4 34.6 26.2
Cervix Uteri 0.8 0.8 0.9 0.3 1.0 1.1
Kidney and Renal Pelvis 1.2 1.0 2.6 0.4 1.3 0.9
Urinary Bladder 2.6 1.8 3.9 1.8 2.5 1.1
Acute Myeloid Leukaemia 0.6 0.5 0.3 0.4 0.0 0.0
Sub-total 65.6 56.5 85.3 49.8 71.9 51.9
Cardiovascular Diseases
Ischemic Heart Disease 48.3 31.4 38.3 24.7 45.2 46.3
Other Heart Disease 13.6 10.8 11.3 17.1 12.7 11.3
Cerebrovascular Disease 27.1 26.5 27.1 22.4 26.6 30.9
Atherosclerosis 0.8 0.4 0.0 0.1 0.8 0.5
Aortic Aneurysm 11.0 5.0 10.6 7.4 11.9 8.8
Other Arterial Disease 1.6 0.7 0.5 0.4 0.9 0.5
Sub-total 102.4 74.8 87.8 72.1 98.1 98.3
Respiratory Diseases
Pneumonia, Influenza 17.2 9.4 7.6 7.9 11.7 7.5
Bronchitis, Emphysema 8.1 4.3 11.3 4.0 15.9 7.8
Chronic Airway Obstruction 41.2 30.5 54.4 33.1 52.5 26.8BMC Public Health 2009, 9:206 http://www.biomedcentral.com/1471-2458/9/206
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[14,43]. The prevalence by sex and two age groups were
shown in Table 1. A survey on risk factors for coronary
artery disease conducted in 19 cities in Rio Grande do Sul
in 1999–2000 showed that the smoking prevalence was
33.9% (CI 95% 31.0–36.8) [44]. Not only smoking prev-
alence was lower in the capital as compared to the other
cities, but also smoking intensity was lower: 13% of the
smokers in Porto Alegre consumed more than twenty cig-
arettes per day [14], contrasting with the 52.5% in the
other cities [44].
Lopez et al proposed the tobacco pandemic model in
1994 [45]. This is a four-stage model defined by changes
in three variables: prevalence of adult smoking, consump-
tion of tobacco (the amount smoked per adult in a given
period) and Smoking Attributable Mortality. This model
shows that the lag time between the rise in smoking prev-
alence and the rise in SAM is about three-to-four decades
[45]. Different tobacco control activities would be neces-
sary to tackle each of the four stages of the cigarette epi-
demic [45]. As a result of the Brazilian National Tobacco
Control Program (NTCP), social acceptance of smoking is
declining in the country overall. Brazil has a comprehen-
sive tobacco control policy, which includes bans on
tobacco advertising, promotion and sponsorship; health
warnings on packages; ban on over-the-counter sales to
under 18 year-olds, prohibition of smoking in public
establishments and health promotion and education pro-
grams in schools. Another important way to address the
problem of tobacco use is to provide access to effective
treatments. Percentages of former smokers are the best
measure of smoking cessation at a population level [46].
The prevalence of smoking in Brazil has declined substan-
tially between 1989 and 2003 [19,43] and a high smoking
cessation index (number of ex-smokers divided by the
number of smokers plus the number of ex-smokers) in the
16 cities varied from 44% in João Pessoa (northeastern
Brazil) to 58% in Campo Grande (west-central Brazil)
[14,43]. These figures are very similar to those found in
the United States in 2002 [47]. Success in reducing smok-
ing prevalence is likely to lower the burden of SAM in
future decades [29]. However, it is important to highlight
that the decline in smoking prevalence was less marked
among lower socioeconomic strata and the reduction in
the mean number of cigarettes smoked per day (from 13.3
to 11.6) was modest [19]. This must be addressed in order
to prevent an increase in health related inequities in the
country.
Another important indicator of improvement in tobacco
control is the decline in proportion of household expend-
Sub-total 66.5 44.2 73.3 45.0 80.1 42.1
Total 234.5 175.5 246.4 166.9 250.1 192.3
1 Among adults aged 35 years and older
2 Does not include burn or second hand smoke deaths.
Table 3: Age-adjusted smoking attributable mortality (SAM)1,2 rates per 100,000 inhabitants, according to cause of death in selected 
cities, Brazil, 2003. (Continued)
Table 4: Smoking-Attributable YPLL1,2 by city, cause of death 
and sex in 16 Brazilian cities, 2003.
City Male Female Total
Aracaju 2,237 925 3,162
Belém 8,044 4,175 12,219
Belo Horizonte 16,888 7,833 24,721
Brasília 10,385 5,831 16,216
Campo Grande 5,139 2,617 7,756
Curitiba 14,483 8,435 22,918
Florianópolis 3,114 1,113 4,227
Fortaleza 9,196 5,681 14,877
João Pessoa 3,559 1,842 5,401
Manaus 6,142 3,051 9,193
Natal 3,687 2,061 5,748
Porto Alegre 17,677 8,422 26,099
Recife 11,485 7,094 18,579
Rio de Janeiro 58,318 29,034 87,352
São Paulo 107,434 50,978 158,412
Vitória 2,202 853 3,055
TOTAL 279,990 139,945 419,935
1 Among adults aged 35 years and older.
2 Does not include burn or second hand smoke deaths.BMC Public Health 2009, 9:206 http://www.biomedcentral.com/1471-2458/9/206
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iture on tobacco: from 3% in 1995–1996 to 2% in 2002–
2003 [42]. The annual consumption of cigarettes per cap-
ita among people older than 15 years also decreased from
1,950 cigarettes per capita in 1986 to 1,337 in 1998, and
further to 1,194 in 2001 [48]. This data allows the 16 cap-
itals of the country to be categorized at stage III of the
tobacco pandemic model [45].
A number of considerations regarding the Brazilian NTCP
must be addressed. Firstly, unlike the U.S., Canada and
other countries, the smoke-free indoor movement is only
incipient in Brazil. The number of public and work places
which restrict or do not allow smoking is still very limited.
Recent data from the Global Youth Tobacco Survey
(GYTS) in 16 Brazilian State capitals and the Federal Dis-
trict showed that exposure to second hand smoke (SHS)
in public places varied from 41.9% in Salvador to 62.2%
in Porto Alegre [49]. Another recent study showed that
Brazil ranked third in the rates of tobacco use during preg-
nancy, with Uruguay leading (18.3%), followed by Argen-
tina (10.3%) and Brazil (6.1%) [50]. Female-driven
educational campaigns and bans on indoor smoking are
important cost-effective tobacco control policies [51,52]
that need to be pursued in Brazil.
Conclusion
This is the first study estimating the smoking attributable
mortality for Brazil. The classic tobacco pandemic model
explains why, despite its decreasing prevalence, smoking
still causes one out of five male deaths and one out of ten
female deaths from all causes in 16 Brazilian capitals in
2003. The present mortality burden attributable to smok-
ing in the 16 Capitals studied is approximately 25,000
deaths or more, and almost half a million years of poten-
tial life (279,990 years in men and 139,945 in women)
were lost as a result. This reflects only part of the impact
of smoking on the health of the Brazilian population,
since morbidity, disability and costs associated with this
behavior have not been analyzed.
In 2002, Brazil was categorized as a country at stage II in
the classic model of the tobacco pandemic [53]. These
results, taken together with the declining annual Brazilian
consumption of cigarettes per capita and the degree of
social denormalization of cigarette smoking in Brazil,
allows us to classify the sixteen studied capitals at stage III
in the tobacco pandemic model.
There is a lack of information on smoking-attributable
mortality from developing countries. The current esti-
mates of SAM and YPLL in Brazilian society are unaccept-
able. Despite significant progress in tobacco control in
Brazil in recent years, further policies and interventions
aimed at reducing SAM need to be implemented. These
include enforcing existing laws that prohibit single ciga-
rette sales, more effective use of price instruments, the cre-
ation and enforcement of 100% smoke-free
environments, further restrictions on point-of-sale
tobacco advertising and strategies to encourage smoking
cessation.
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